Australia's AI Scribes Bypass Safety Reviews as Use Doubles

Australia's AI Scribes Bypass Safety Reviews as Use Doubles

Australian doctors using AI to record patient notes jumped from 22% to 40% in 16 months. The technology avoids regulation because the Therapeutic Goods Administration classifies it as documentation only, not a medical device. This means no pre-market testing, no adverse-event tracking, and no data-handling standards. Regulators are considering safeguards, but none exist.

Published

Read at another depth